Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Averting the Unthinkable: Immunization to Prevent Childhood Deaths From Influenza.

Pediatrics·2026

Same author

Malaria in Children at 9 US Hospitals: 2016-2023.

Pediatrics·2026

Same author

RodA promotes intestinal colonization by group B <i>Streptococcus</i>.

Infection and immunity·2026

Same author

Pneumococcal Pneumonia: Understanding the Past to See the Future.

Pediatrics·2026

Same author

Epidemiologic characteristics of invasive group B streptococcal infections caused by rare serotypes among adults in the United States, 2007-2023.

PLOS global public health·2026

Same author

Correction for Bhavana et al., "A group B <i>Streptococcus</i> indexed transposon mutant library to accelerate genetic research on an important perinatal pathogen".

Microbiology spectrum·2026

Search research articles

Related Experiment Video

Updated: Nov 27, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Multisystem inflammatory syndrome in children.

Vijaya L Soma¹, Gail F Shust¹, Adam J Ratner^1,2

¹Department of Pediatrics, Division of Infectious Diseases, New York University Grossman School of Medicine and Hassenfeld Children's Hospital.

Current Opinion in Pediatrics

|December 5, 2020

Summary

This summary is machine-generated.

Multisystem inflammatory syndrome in children (MIS-C) is a serious COVID-19 complication. Early identification and varied management, from supportive care to immune modulation, are crucial for affected children.

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

Related Experiment Videos

Last Updated: Nov 27, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

Area of Science:

Pediatric infectious diseases
Immunology
Critical care medicine

Background:

Multisystem inflammatory syndrome in children (MIS-C) is a significant postinfectious complication associated with COVID-19.
It presents with widespread inflammation affecting multiple organ systems.

Purpose of the Study:

To summarize current knowledge on MIS-C for clinicians.
To aid in the identification and management of MIS-C cases.

Main Methods:

Review of current literature and clinical knowledge on MIS-C.
Analysis of clinical presentations, diagnostic challenges, and management strategies.

Main Results:

MIS-C commonly features fever, gastrointestinal issues, cardiac dysfunction, and hypotension.
While resembling Kawasaki disease, MIS-C involves distinct inflammatory pathways.
Diagnosis requires a broad approach due to overlapping symptoms with other conditions.

Conclusions:

MIS-C management is variable, ranging from supportive care to aggressive immune modulation, tailored to illness severity.
A multidisciplinary team approach is recommended for complex cases.
Further research is needed on long-term outcomes and immunologic data to refine diagnosis and treatment.